Graves disease is antibody-driven hyperthyroidism: TSH receptor antibodies switch on the whole gland, so a younger woman has a smooth, diffuse goiter, eye disease, and diffusely increased uptake on a radioactive iodine scan. Toxic multinodular goiter is autonomous hyperthyroidism: several nodules make hormone on their own, so an older patient has a lumpy, irregular goiter, no eye findings, and patchy uptake with hot nodules on the scan. Both suppress the TSH and raise the free T4 or T3. On COMLEX, the age, the shape of the gland, the eyes, and the uptake pattern separate them.
The labs alone won't split these two. A suppressed TSH tells you the patient is thyrotoxic, not why. The question writers hide the answer in the demographics, the physical exam, and the scan. Once you know what each one does to the gland, these questions become some of the most predictable endocrine points on the exam.
Why do boards pair Graves disease with toxic multinodular goiter?
They are the two most common causes of hyperthyroidism with a high radioactive iodine uptake. Graves is the most common cause overall in the United States. Toxic multinodular goiter is the second most common, and it becomes more common with age and in regions with low dietary iodine.
That shared high uptake is the trap. Students learn "high uptake means the gland is overproducing" and stop there. That's correct, and it rules out thyroiditis and exogenous hormone. It does not tell you which overproducing gland you're looking at. The distribution of the uptake does.
The two diseases also treat differently. Graves can go into remission on antithyroid drugs. Toxic multinodular goiter almost never does, because the nodules stay autonomous. So the "next best step" questions depend on getting the diagnosis right first.
What drives the gland in each disease?
Graves disease: an antibody that acts like TSH
Graves disease is a type II hypersensitivity reaction. The patient makes IgG antibodies (thyroid-stimulating immunoglobulins, also called TSH receptor antibodies or TRAb) that bind the TSH receptor and activate it. Every follicular cell in the gland gets the same signal at the same time. The result is diffuse hyperplasia, a symmetric goiter, and increased blood flow through the whole gland.
The TSH receptor also sits on orbital fibroblasts and on fibroblasts in the pretibial skin. That's why Graves causes findings outside the thyroid. The antibody and the T cells it recruits make those fibroblasts lay down glycosaminoglycans and proliferate, which swells the extraocular muscles and orbital fat and thickens the shin skin.
Histology shows tall columnar follicular cells crowding into the follicle lumen, with scalloped, pale colloid at the edges. Lymphocytic infiltrates are common. Graves is associated with HLA-DR3 and HLA-B8 and with other autoimmune diseases, including type 1 diabetes, pernicious anemia, and vitiligo.
Because TRAb is IgG, it crosses the placenta. A mother with Graves, even one who has been treated with radioactive iodine or surgery and is now euthyroid, can deliver a baby with transient neonatal hyperthyroidism.
Toxic multinodular goiter: nodules that ignore TSH
Toxic multinodular goiter, also called Plummer disease, starts as a long-standing nontoxic multinodular goiter. Over years, some of the nodules acquire activating somatic mutations, most often in the TSH receptor gene and less often in the Gs alpha subunit. Those nodules now make hormone without any TSH signal.
As the autonomous nodules produce more hormone, the pituitary shuts off TSH. The normal tissue between the nodules loses its stimulus and goes quiet. That's the whole story of the scan: a few bright nodules on a suppressed background.
There's no antibody in this disease. The TRAb is negative, and there is no eye disease or dermopathy. The gland just grows irregularly over decades, which is why the patient is older and the goiter can be large enough to compress the trachea or esophagus.
Graves disease vs toxic multinodular goiter side by side
| Feature | Graves disease | Toxic multinodular goiter |
|---|---|---|
| Mechanism | TSH receptor stimulating antibodies (type II hypersensitivity) | Autonomous nodules from activating TSH receptor or Gs alpha mutations |
| Typical patient | Woman, roughly 20 to 50 years old | Patient over 50 to 60 with a long-standing goiter |
| Geography clue | None | Iodine-deficient region or immigrant from one |
| Goiter shape | Diffuse, smooth, symmetric, often with a bruit or thrill | Irregular, lumpy, asymmetric, may extend substernally |
| Eyes | Proptosis, periorbital edema, extraocular muscle swelling, diplopia | No true ophthalmopathy (lid lag possible from adrenergic tone) |
| Skin | Pretibial myxedema, thyroid acropachy | None |
| Severity | Often overt, florid adrenergic symptoms | Often milder, subclinical, or T3-predominant |
| Common presentation in older patients | Less common | Atrial fibrillation, heart failure, weight loss with few adrenergic signs |
| TRAb (TSI) | Positive | Negative |
| Radioactive iodine uptake | Increased | Normal to increased |
| Scan pattern | Diffuse, homogeneous uptake | Patchy, heterogeneous uptake with multiple hot nodules and suppressed background |
| Doppler ultrasound | Diffusely increased flow | Multiple nodules, flow within nodules |
| Remission on methimazole | Possible | Rare |
| Preferred definitive treatment | Radioactive iodine, surgery, or a long course of methimazole | Radioactive iodine or surgery |
Drill this until you can rebuild it from memory. A COMLEX stem will usually hand you three or four rows and expect you to fill in the rest.
What does the physical exam tell you?
Start with the eyes. Lid lag and lid retraction happen in any thyrotoxic patient, because excess thyroid hormone increases sympathetic tone on the levator palpebrae (the superior tarsal muscle). That stare doesn't diagnose Graves. True proptosis, periorbital edema, chemosis, and restricted eye movement with double vision come from the orbital fibroblast process, and only Graves causes that.
Then feel the gland. A smooth, diffusely enlarged, nontender thyroid with a bruit over it is Graves until proven otherwise. The bruit reflects the increased blood flow through a gland that's being stimulated everywhere. A gland with several firm, discrete nodules of different sizes points to toxic multinodular goiter.
Look at the shins and fingers. Pretibial myxedema is a raised, nonpitting, orange-peel plaque on the anterior lower legs. Thyroid acropachy looks like clubbing with soft tissue swelling of the fingers. Both are rare, both are specific to Graves, and both travel with ophthalmopathy.
Finally, check for compression. A large multinodular goiter can cause dysphagia, dyspnea, stridor, or hoarseness. If it extends behind the sternum, raising both arms can cause facial plethora and venous congestion (Pemberton sign). Graves goiters are rarely big enough to do this.
How do you read the radioactive iodine uptake and scan?
The uptake and scan answer two different questions. The uptake number answers "is the gland making new hormone?" The scan picture answers "which parts of the gland are making it?"
The uptake number
A high uptake means the gland is actively trapping iodine to make new hormone. That fits Graves, toxic multinodular goiter, and toxic adenoma. A low uptake means the hormone isn't coming from new synthesis in the neck.
Low-uptake thyrotoxicosis on boards means one of a short list: subacute granulomatous (de Quervain) thyroiditis with a painful, tender gland after a viral illness; painless or postpartum thyroiditis; Hashitoxicosis; exogenous thyroid hormone, where the serum thyroglobulin is also low; a recent iodine load; or struma ovarii, where the uptake lights up the pelvis instead of the neck.
In toxic multinodular goiter, the total 24-hour uptake can be only mildly elevated or even normal. Don't let a normal uptake number talk you out of the diagnosis if the scan shows hot nodules on a suppressed background.
The scan picture
The scan is where these two diseases separate cleanly.
| Scan pattern | Diagnosis |
|---|---|
| Diffuse, homogeneous, increased uptake across both lobes | Graves disease |
| Multiple hot nodules, heterogeneous uptake, suppressed tissue between them | Toxic multinodular goiter |
| One hot nodule, the rest of the gland suppressed | Toxic adenoma |
| Little or no uptake anywhere in the neck | Thyroiditis, exogenous hormone, iodine load, or struma ovarii |
Hot nodules are almost never malignant, so a hyperfunctioning nodule generally doesn't need a fine-needle aspiration. A cold nodule in a multinodular gland is a different question and gets evaluated on its own ultrasound features.
When the scan isn't the answer
The 2016 American Thyroid Association guideline lists three ways to establish the cause of thyrotoxicosis: TRAb, radioactive iodine uptake, or thyroid blood flow on Doppler ultrasound. In pregnancy and breastfeeding, radioactive iodine is contraindicated, so the next step is a TRAb level rather than a scan. That's a favorite question part on both COMLEX and USMLE.
Who gets each disease on a board stem?
The demographics do a lot of the work before you ever reach the labs.
The classic Graves patient is a woman in her 20s to 40s with palpitations, heat intolerance, weight loss despite a big appetite, a fine tremor, frequent stools, and anxiety. She may mention that her eyes feel gritty or look different in photos. A family history of autoimmune thyroid disease and a history of smoking both push toward Graves, and smoking makes the eye disease worse.
The classic toxic multinodular goiter patient is in their 60s or 70s and has had a "lump in the neck" or a goiter for years. The symptoms are often quieter. Older patients frequently present with new atrial fibrillation, worsening heart failure, or unexplained weight loss rather than tremor and anxiety. This is sometimes called apathetic hyperthyroidism, and it's easy to miss if you only look for the young-patient symptoms.
The iodine trigger
Watch the timeline in the stem. A patient with a known nodular goiter who becomes thyrotoxic a few weeks after a CT scan with iodinated contrast, or after starting amiodarone, has the Jod-Basedow phenomenon. The autonomous nodules finally get enough iodine substrate and produce a burst of hormone. This is a toxic multinodular goiter story, not a Graves story.
How does treatment differ?
Both diseases get a beta-blocker for symptom control while you work up and treat the cause. Propranolol is the classic board answer, and at higher doses it also reduces peripheral conversion of T4 to T3.
Graves disease
There are three options, and the patient's situation picks among them.
- Antithyroid drugs. Methimazole is first-line. Propylthiouracil is preferred in the first trimester of pregnancy because methimazole is teratogenic early on, and it's also used in thyroid storm. Both can cause agranulocytosis, so a fever or sore throat on therapy means stopping the drug and checking a neutrophil count. Propylthiouracil carries a boxed warning for severe liver injury. A course of about 12 to 18 months gives some patients a lasting remission.
- Radioactive iodine ablation. It's effective and usually leads to permanent hypothyroidism that needs levothyroxine. It can worsen active ophthalmopathy, so mild active eye disease gets steroid coverage, and moderate-to-severe active eye disease steers the choice toward drugs or surgery. It's contraindicated in pregnancy and breastfeeding.
- Thyroidectomy. It's preferred for a large goiter, a suspicious nodule, or significant eye disease, and for women planning pregnancy soon. Watch for hypocalcemia from parathyroid injury and hoarseness from recurrent laryngeal nerve injury afterward.
Moderate-to-severe thyroid eye disease is treated with glucocorticoids, and teprotumumab (an IGF-1 receptor blocker) is now used for active disease. Stopping smoking is part of every Graves eye plan.
Toxic multinodular goiter
The nodules stay autonomous, so methimazole controls the hormone level but almost never produces remission. Definitive therapy is radioactive iodine or surgery. Surgery is favored when the goiter is large, compressive, or substernal, or when a nodule looks suspicious for cancer. Radioactive iodine is a good choice for an older patient with a smaller goiter and higher surgical risk. Long-term low-dose methimazole is a reasonable option for a patient who can't have either.
After radioactive iodine, the suppressed normal tissue often wakes back up. That's why hypothyroidism after ablation is less common in toxic multinodular goiter than in Graves.
Stem clues that crack these questions fast
The clues I look for in every question are age, acuity, unusual findings, matching timelines, laterality, labs and imaging, and the question part. Here's how they apply to the thyroid.
- Age. A 28-year-old woman with a thyrotoxic picture is Graves until the stem tells you otherwise. A 72-year-old with new atrial fibrillation and a lumpy neck is toxic multinodular goiter.
- Acuity. Graves symptoms tend to build over weeks to months. Toxic multinodular goiter grows over years, and a sudden worsening after contrast or amiodarone is the Jod-Basedow tip-off.
- Unusual findings. A stem rarely mentions the shins, a bruit, or diplopia by accident. Pretibial myxedema, a thyroid bruit, and restricted eye movement each point to Graves.
- Matching timelines. Thyrotoxicosis two weeks after a contrast CT points to iodine. Thyrotoxicosis a few months after delivery points to postpartum thyroiditis, which has low uptake.
- Laterality. Graves stimulates the whole gland evenly, so the goiter and the uptake are symmetric. An asymmetric, irregular gland or patchy uptake points away from Graves.
- Labs and imaging. The objective findings are king. TRAb positive with diffuse uptake is Graves. TRAb negative with hot nodules on a suppressed background is toxic multinodular goiter.
- The question part. "Most likely mechanism," "best next step in diagnosis," and "most appropriate definitive treatment" each want a different answer for the same patient. Read the last sentence slowly before you commit.
When two answers both look right on an endocrine question, the guide to choosing between two answers on COMLEX walks through how to break the tie.
Common board pitfalls and how to avoid them
Calling lid lag Graves. Lid lag and a staring look come from adrenergic overdrive in any thyrotoxic state. Proptosis, periorbital edema, and diplopia are the Graves-specific eye findings.
Stopping at a high uptake. A high uptake narrows the list to Graves, toxic multinodular goiter, and toxic adenoma. The scan pattern picks among them.
Ordering a scan in a pregnant patient. Radioactive iodine is contraindicated in pregnancy. Order TRAb instead.
Expecting remission in toxic multinodular goiter. Autonomous nodules don't burn out on methimazole. Definitive therapy is radioactive iodine or surgery.
Missing apathetic hyperthyroidism. An older patient with atrial fibrillation and weight loss needs a TSH even without tremor or anxiety.
Giving iodine to a patient with an autonomous goiter. Iodinated contrast and amiodarone can trigger thyrotoxicosis in a nodular gland. That's the Jod-Basedow phenomenon.
Choosing radioactive iodine for a Graves patient with severe active eye disease. Ablation can make the orbitopathy worse. Drugs or surgery come first in that patient.
Frequently asked questions about Graves disease vs toxic multinodular goiter
What is the main difference between Graves disease and toxic multinodular goiter?
Graves disease is autoimmune. TSH receptor stimulating antibodies activate the entire gland, causing a diffuse goiter, eye disease, and diffuse uptake on the scan, usually in a younger woman. Toxic multinodular goiter is caused by several nodules that make hormone independently of TSH, causing an irregular goiter and patchy uptake with hot nodules, usually in an older patient. Graves has positive TRAb, and toxic multinodular goiter does not.
What does the radioactive iodine scan show in Graves vs toxic multinodular goiter?
Graves shows diffuse, homogeneous, increased uptake across both lobes. Toxic multinodular goiter shows heterogeneous uptake with several hot nodules and suppressed tissue between them, and the total uptake number may be only mildly elevated or normal. A single hot nodule with a suppressed remainder is a toxic adenoma. Little or no uptake points to thyroiditis, exogenous hormone, or an iodine load.
Does toxic multinodular goiter cause exophthalmos?
No. True ophthalmopathy (proptosis, periorbital edema, extraocular muscle swelling, diplopia) comes from TSH receptor antibodies acting on orbital fibroblasts, and only Graves has those antibodies. A patient with toxic multinodular goiter can have lid lag or lid retraction, because any thyrotoxic state increases sympathetic tone on the eyelid muscle.
What is the Jod-Basedow phenomenon?
Jod-Basedow is iodine-induced hyperthyroidism. A patient with autonomous thyroid nodules, often from an iodine-deficient region, receives a large iodine load from iodinated contrast or amiodarone. The autonomous nodules use the extra substrate to make excess hormone, and the patient becomes thyrotoxic within weeks. It is a classic trigger for toxic multinodular goiter on board exams.
Which test do you order to diagnose Graves disease in pregnancy?
Order a TSH receptor antibody (TRAb) level. Radioactive iodine uptake and scan are contraindicated in pregnancy and breastfeeding. TRAb also matters for the baby, because the IgG antibody crosses the placenta and can cause fetal or neonatal hyperthyroidism, even in a mother who was previously treated with ablation or surgery.
Why is radioactive iodine or surgery preferred for toxic multinodular goiter?
The hyperfunctioning nodules carry activating mutations, so they stay autonomous for life. Methimazole lowers hormone levels while it is taken, but remission after stopping is rare. Radioactive iodine or surgery removes the source permanently. Surgery is favored for a large, compressive, or substernal goiter, or for a nodule that looks suspicious for cancer.
Get more clinical breakdowns like this in the free Skool community
The Premeducated free Skool community has a 100-plus video library of question breakdowns, weekly office hours with physician tutors, and cloze-deletion Anki cards transcribed directly from Lucas's video library. Free, no upgrade required.
Related guides
- Hyperthyroidism vs hypothyroidism: board-relevant differences for COMLEX and USMLE
- Cushing's vs Addison's disease on board exams
- Central vs nephrogenic diabetes insipidus on COMLEX and USMLE
- SIADH vs cerebral salt wasting on board exams
- How do I choose between two answers on COMLEX?
- Doctor Lucas DO on YouTube: endocrine question breakdowns and high-yield clinical comparison videos